10-Q: Birchtech Corp. Reports Q3 2026 Results, Faces Net Loss

Birchtech Corp. reported a net loss of $275,000 for Q3 2026, a significant decrease from the prior year's net income, impacted by lower gross profit and increased R&D expenses, though cash reserves increased substantially post-offering.

Summary

• Birchtech Corp. reported a net loss of $274,983 for the three months ended September 30, 2026, compared to a net income of $788,012 in the same period of 2025. For the nine months ended September 30, 2026, the net loss was $4,637,982, an increase from $2,433,124 in the prior year.
• Revenues for the three months ended September 30, 2026, were $5,506,350, down from $7,361,889 in the prior year, primarily due to the absence of licensing revenue. Product revenue increased to $5,455,683 from $4,715,874.
• Cost of sales increased to $3,859,783 for the three months ended September 30, 2026, from $3,329,638 in the prior year, leading to a decrease in gross profit to $1,646,567 from $4,032,251.
• Operating expenses saw a decrease in SG&A to $1,788,809 from $2,748,100, but R&D expenses increased to $472,835 from $473,303 for the three-month period, with a larger increase for the nine-month period.
• The company's cash position significantly improved, with cash and cash equivalents totaling $10,827,922 at September 30, 2026, up from $2,245,426 at December 31, 2025, largely due to proceeds from a public offering.
• The company is actively involved in patent litigation, with a final judgment of $78,397,157 awarded in December 2025 in a Delaware case, which is currently under appeal. New patent infringement lawsuits were also filed in 2024 and 2025.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to the net loss reported, increased operating expenses, and ongoing legal proceedings, despite a significant increase in cash reserves from a recent public offering.

Positives

• Cash and cash equivalents increased significantly to $10,827,922 as of September 30, 2026, from $2,245,426 as of December 31, 2025, primarily due to proceeds from a public offering.
• Working capital improved to $3,605,000 at September 30, 2026, from a deficit of $5,737,000 at December 31, 2025.
• Product revenue increased by approximately 15.7% to $5,455,683 for the three months ended September 30, 2026, compared to $4,715,874 in the prior year period.
• Selling, general, and administrative (SG&A) expenses decreased by approximately $959,000 for the three-month period and $779,000 for the nine-month period.
• The company has made progress in resolving patent litigation, with several agreements and dismissals, and a significant judgment awarded in the Delaware case, though it is under appeal.

Negatives

• The company reported a net loss of $274,983 for the three months ended September 30, 2026, a reversal from a net income of $788,012 in the prior year.
• For the nine months ended September 30, 2026, the net loss widened to $4,637,982 from $2,433,124 in the prior year.
• Total revenues decreased to $5,506,350 for the three months ended September 30, 2026, from $7,361,889 in the prior year, largely due to the absence of licensing revenue.
• Gross profit decreased significantly to $1,646,567 for the three months ended September 30, 2026, from $4,032,251 in the prior year, driven by a shift in revenue mix and increased cost of sales.
• Research and development expenses increased by approximately $276,000 for the nine months ended September 30, 2026, compared to the prior year period.
• The company has material weaknesses in internal control over financial reporting due to a lack of sufficient personnel and insufficient documentation/training of internal control policies.

Risks

• The loss of any one of the major customers could have an adverse effect on the Company's operations.
• The Company's patent litigation is ongoing, with a pending appeal of a significant judgment and one remaining active case, the outcome of which cannot be predicted.
• The Company is exposed to risks associated with rising material costs during the term of fixed-price contracts.
• The Company's common stock has experienced varied and, at times, limited trading activity and price volatility.
• The Company's business is subject to risks related to advancements in technologies and the development and growth of new technologies, particularly in the water treatment market.
• The Company faces risks related to intellectual property, including the ability to protect intellectual property and the success of any patent litigation.

Future Outlook

Management believes the Company has sufficient liquidity to fund operations for at least twelve months from the issuance date of the financial statements, based on net proceeds from the public offering, existing cash, anticipated revenues, and additional cash inflows from current operations. The company is developing water purification technologies and plans to open and operate commercial thermal reactivation plants in the future.

Management Comments

• Management believes that the Company has sufficient liquidity to fund its operations and meet its obligations for at least twelve months from the date of issuance of these unaudited condensed consolidated financial statements.
• Management believes that the Company is well positioned to capture a meaningful share in the rapidly growing water treatment sector.
• We cannot predict the ultimate outcome of the remaining litigation or the pending appeal of the Delaware judgment.

Industry Context

StockSavvy.ai notes that Birchtech Corp. operates in the environmental technology sector, focusing on mercury emissions capture for coal-fired utilities and developing water purification technologies for PFAS. The company's performance is influenced by environmental regulations like the MATS rule and emerging water quality standards, as well as energy market dynamics such as natural gas prices.

Comparison to Industry Standards

• The company's mercury removal technologies aim to meet or exceed EPA's MATS requirements at a lower cost and with less operational impact than typical PAC or BAC sorbent injection systems.
• The company's water treatment solutions target compliance with emerging PFAS regulations, such as the EPA's national drinking water standard, which established legally enforceable MCLs for six PFAS.
• The company's development of a carbon reactivation process (Carbon RejuvenationTM) aims to offer a sustainable and cost-effective alternative to virgin carbon for water utilities, addressing key questions about media changeout schedules and operational costs.

Corporate Governance

Legal Proceedings

• The Company is involved in ongoing patent infringement lawsuits to enforce its proprietary two-part Sorbent Enhancement Additive (SEA) process for mercury removal.
• A final judgment of $78,397,157 was awarded in December 2025 in a Delaware patent litigation case, which is currently under appeal by the defendants.
• One active patent infringement case remains pending against one utility, which was remanded to the U.S. District Court for the Eastern District of Missouri.
• The Company is involved in a dispute with a third party regarding invoices and claimed charges totaling $184,079, which the Company disputes.

Related Party Transactions

• Kaye Cooper Kay & Rosenberg, LLP provided legal services; David M. Kaye, a Director, was a partner until February 28, 2026, and continued to provide services directly.
• For the three months ended September 30, 2026, the Company incurred $116,587 for legal services from the firm and Mr. Kaye.
• For the nine months ended September 30, 2026, the Company incurred $507,208 for legal services from the firm and Mr. Kaye.
• At September 30, 2026, $37,500 was owed for services rendered by Mr. Kaye.
• At September 30, 2026, the Company owed $16,428 to its Chief Operating Officer and $2,373 to its Chief Technology Officer for expense reimbursements.

Stakeholder Impact

• Shareholders may be impacted by the net loss, increased operating expenses, and ongoing legal proceedings, despite the improved cash position from the recent offering.
• Customers in the coal-fired utility sector may be affected by the company's focus on mercury emissions control and potential shifts in environmental regulations.
• Customers in the water treatment sector may benefit from the company's development of new technologies for PFAS and other contaminants.
• Suppliers may be impacted by the company's concentration of purchases from a few key vendors.

Next Steps

• Continue to enforce patent rights against unauthorized use of patented technologies.
• Develop disruptive water purification technologies with a specialization on forever chemicals such as PFAS and PFOS.
• Invest in the commissioning of laboratory facilities for water treatment innovation and development.
• Plan for the future opening and operation of commercial thermal reactivation plants.
• Continue to monitor and respond to evolving water regulations and funding dynamics.
• Pursue resolution of remaining patent litigation and appeal of the Delaware judgment.

Key Dates

Recommendation

The company's improved cash position from the recent offering is a positive, but the continued net losses, declining revenues (excluding product sales), and significant ongoing legal battles present substantial risks. The shift in focus to water treatment is promising but still in development. A 'hold' recommendation reflects the balance between potential future growth and current financial and legal uncertainties.

Keywords

mercury emissions, activated carbon, water purification, PFAS, patent litigation, public offering, MATS rule, Sorbent Enhancement Additive